Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

The Lancet

Volumn 372, Issue 9648, 2008, Pages 1484-1492

  Bercovich, Dani ^a   Ganmore, Ithamar ^b,c   Scott, Linda M ^d   Wainreb, Gilad ^c   Birger, Yehudit ^b,c   Elimelech, Arava ^a   Shochat, Chen ^a   Cazzaniga, Giovanni ^e   Biondi, Andrea ^e   Basso, Giuseppe ^f   Cario, Gunnar ^g   Schrappe, Martin ^g   Stanulla, Martin ^h   Strehl, Sabine ⁱ   Haas, Oskar A ⁱ   Mann, Georg ⁱ   Binder, Vera ^j   Borkhardt, Arndt ^j   Kempski, Helena ^k   Trka, Jan ^l   Bielorei, Bella ^b,c   Avigad, Smadar ^m   Stark, Batia ^m   Smith, Owen ⁿ   Dastugue, Nicole ^o   Bourquin, Jean Pierre ^p   Tal, Nir Ben ^c   Green, Anthony R ^d   Izraeli, Shai ^b,c   more..

^a TEL HAI COLLEGE   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ ST ANNA CHILDREN S HOSPITAL   (Austria)

^j UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^k GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^l CHARLES UNIVERSITY   (Czech Republic)

^m SCHNEIDER CHILDREN'S HOSPITAL   (United States)

ⁿ TRINITY COLLEGE DUBLIN   (Ireland)

^o TOULOUSE UNIVERSITY HOSPITAL   (France)

^p UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; JANUS KINASE 2; STAT PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLELE; ANIMAL CELL; ARTICLE; BONE MARROW; CHILD; CHROMOSOME 21Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA SCREENING; DOWN SYNDROME; ENZYME ACTIVATION; FEMALE; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; THROMBOCYTHEMIA;

EID: 54349086521     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61341-0     Document Type: Article

References (29)

1. Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2 (2001) 429-436
2. Wechsler J., Greene M., McDevitt M.A., et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 32 (2002) 148-152
3. Rainis L., Bercovich D., Strehl S., et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102 (2003) 981-986
4. Vyas P., and Roberts I. Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis. Early Hum Dev 82 (2006) 767-773
5. Groet J., McElwaine S., Spinelli M., et al. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet 361 (2003) 1617-1620
6. Pui C.H., Campana D., and Evans W.E. Childhood acute lymphoblastic leukaemia-current status and future perspectives. Lancet Oncol 2 (2001) 597-607
7. Whitlock J.A., Sather H.N., Gaynon P., et al. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 106 (2005) 4043-4049
8. Forestier E., Izraeli S., Beverloo B., et al. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome-an iBFM-SG study. Blood 111 (2008) 1575-1583
9. Scott L.M., Tong W., Levine R.L., et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 356 (2007) 459-468
10. Campbell P.J., and Green A.R. The myeloproliferative disorders. N Engl J Med 355 (2006) 2452-2466
11. Levine R.L., Wadleigh M., Cools J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7 (2005) 387-397
12. Kralovics R., Passamonti F., Buser A.S., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
13. James C., Ugo V., Le Couedic J.P., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
14. Walters D.K., Mercher T., Gu T.L., et al. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 10 (2006) 65-75
15. Norton A., Fisher C., Liu H., et al. Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome. Blood 110 (2007) 1077-1079
16. Dai X., Chen Y., Di L., et al. Stat5 is essential for early B cell development but not for B cell maturation and function. J Immunol 179 (2007) 1068-1079
17. Lacronique V., Boureux A., Valle V.D., et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278 (1997) 1309-1312
18. Malinge S., Ben-Abdelali R., Settegrana C., et al. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia. Blood 109 (2007) 2202-2224
19. Bercovich D., and Beaudet A.L. Denaturing high-performance liquid chromatography for the detection of mutations and polymorphisms in UBE3A. Genet Test 7 (2003) 189-194
20. D'Andrea A.D., Yoshimura A., Youssoufian H., Zon L.I., Koo J.W., and Lodish H.F. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 11 (1991) 1980-1987
21. Glaser F., Pupko T., Paz I., et al. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19 (2003) 163-164
22. Priest J.H., Blackston R.D., Pearse L.A., and Warren S.T. Molecular evidence for true isochromosome 21q. Hum Genet 81 (1988) 1-3
23. Lu X., Levine R., Tong W., et al. Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. Proc Natl Acad Sci USA 102 (2005) 18962-18967
24. Hertzberg L., Betts D.R., Raimondi S.C., et al. Prediction of chromosomal aneuploidy from gene expression data. Genes Chromosomes Cancer 46 (2007) 75-86
25. Izraeli S., Rainis L., Hertzberg L., Smooha G., and Birger Y. Trisomy of chromosome 21 in leukemogenesis. Blood Cells Mol Dis 39 (2007) 156-159
26. Ribeiro R.C., Sandrini F., Figueiredo B., et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98 (2001) 9330-9335
27. Giordanetto F., and Kroemer R.T. Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Eng 15 (2002) 727-737
28. Pardanani A. JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials. Leukemia 22 (2008) 23-30
29. Flex E., Petrangeli V., Stella L., et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 205 (2008) 751-758